NCT Number: NCT03246737
Premom: Pregnancy Remote Monitoring
Multiple cardiovascular adaptations happen during pregnancy. When gestational hypertensive disorders (GHD) occurs, these adaptations are abnormal. Approximately 5 - 8 % of all pregnant women develop GHD.
GHD is an pregnancy complication which is characterized by an elevated blood pressure (≥ 140/90 mm Hg) and sometimes the appearance of proteinuria (≥3 g/ 24 hours) after twenty weeks of pregnancy. When this remains uncured, GHD can have severe complications for both mother and child. For this reason, a close follow-up of women with a high risk for developing this condition is recommended. This to detect and threat GHD early.
Patients can be included when they are at least 10 weeks pregnant. Every pregnant women receives two devices to control daily here parameters in her home environment: a blood pressure monitor and an activity tracker. The women will be asked to perform two blood pressure measurements a day and to wear the activity tracker day and night. This data will be send by Bluetooth and Wi-Fi to the investigator in the hospital. Also will the women be asked to measure once a week her weight and send this to the hospital.
Name of the device Measurement Protocol Blood pressure monitor Blood pressure, heart rate Twice a day (morning and evening) Activity tracker Activity- and sleep pattern Day and night Weight scale (not remote) Weight Once a week (morning)
The investigator controls daily the incoming measurements and consults the responsible gyneacologist when events (= abnormal blood pressure or weight measurement) occurs. Depending on the decisions of the gyneacologist, following actions can be performed:
* Further observations * Extra monitor * Adjustments to the medication scheme * Performing an 24 hours urine collection * Admission to the prenatal observation ward When results are missing, the investigator contacts the women to ask of this measurement is due to personal or technical causes.
The purpose of this study part is to detect early signs of PE.
When patients gave birth, the data about the delivery (duration of labour, complications, mode of delivery, date of delivery, complications, parameters of the mother, specialties) and the neonate (gestational age, date and hour of birth, Apgar score, birth weight, length, complications and admission to the neonatal intensive care) will be collected. These data will be compared to the data of women who were admitted to the hospital for GHD, but who doesn't receive remote monitoring devices.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Sex eligibility
Female
Study type
Observational
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- > 10 weeks of gestation, in the possession of a Smartphone
Exclusion criteria
- congenital malformations of the fetus
Treatment and study plan
Primary outcomes
-
prenatal follow-up
Time frame: up to 9 months (delivery)
total number of prenatal appointments, monitors, echo's, prenatal hospitalizations, hospitalizations until delivery
Secondary outcomes
-
maternal hemodynamic outcomes
Time frame: Day of delivery
occurrence of essential hypertension/gestational hypertension/pre-eclampsie/help
-
birth weight
Time frame: Day of delivery
neonatal outcome
-
birth length
Time frame: Day of delivery
neonatal outcome
-
Apgar at 1' and 5'
Time frame: Day of delivery
neonatal outcome
-
admission to Neonatal Intensive Care
Time frame: Day of delivery
neonatal outcome
Sponsors and collaborators
Lead sponsor
Hasselt University
Other
Collaborators
- Ziekenhuis Oost-Limburg
Registry information
Acronym: Premom
Important dates
- Study start
- 2015
- Primary completion
- 2015
- Study completion
- 2015
- First posted
- Aug 11, 2017
- Registry last updated
- Aug 11, 2017
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Self-management of Postnatal Anti-hypertensive Treatment: a Trial Development Pilot Study
NCT02333240
Cardiovascular Diseases, Female Urogenital Diseases and Pregnancy Complications
Reading, Berkshire, United Kingdom
View Trial DetailsPhysical Activity and Cardiovascular Profile of Pre-conceptional Women At Risk for GHD
NCT05888467
Cardiovascular Diseases, Cardiovascular Pregnancy Complication
Diepenbeek, Limburg, Belgium
View Trial DetailsThe Heart Outcomes in Pregnancy Expectations for Mom and Baby Study
NCT06517628
Cardiovascular Diseases, Female Urogenital Diseases and Pregnancy Complications
Kansas City, Missouri, United States
View Trial DetailsVitamin D Therapy to Prevent Recurrent Preeclampsia in High-Risk Pregnancies
NCT07717931
Cardiovascular Diseases, Female Urogenital Diseases and Pregnancy Complications
Multan, Punjab Province, Pakistan
View Trial Details